# Bioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers

> **NCT06359626** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 60 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** YHP2205
- **DRUG:** YHR2401

## Key facts

- **NCT ID:** NCT06359626
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-21
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-07-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06359626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06359626, "Bioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06359626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*